Humidified Culture and Live Birth After ICSI

June 9, 2020 updated by: Muhammad Fawzy, Ibn Sina Hospital

Humidified Incubator Effect on Live Birth Rate After ICSI

Humidity for human embryo culture has been raised as essential with advantageous effect on clinical pregnancy and ongoing pregnancy after ICSI compared with a dry incubator. Whether the deleterious effect of dry culture would have an extended effect reaches the live birth rate needs to be examined. This RCT is to examine the effect of dry and humidified culture on live birth rates after ICSI.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

1837

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Assiut, Egypt
        • Banon Assiut
      • Qena, Egypt, 123456
        • Qena Fertility Center
      • Sohag, Egypt
        • IbnSina IVF Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Women undergoing a first or second ICSI attempts
  • Primary or secondary infertility with a BMI of < 31 kg/m2
  • Duration of infertility of ≥ 18 months and normal baseline ultrasonography
  • 18 to 40 years of age
  • Tubal factor, male factor, polycystic ovary, unexplained infertility or combined factors
  • Tubal factors

Exclusion Criteria:

  • Surgically-retrieved, frozen-thawed and pinpoint sperm or globozoospermia
  • Thin endometrium
  • Uterine anomaly and adhesion
  • Adenomyosis
  • Submucous myoma
  • Endometriosis
  • Severe medical condition

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Culture of human embryo in non-humidified incubator
Embryo culture after in vitro fertilization in incubator with no humidity
humidifed or dry incubator
No Intervention: Culture of human embryo in humidified incubator
Embryo culture after in vitro fertilization in incubator with humidity

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Live birth rate
Time Frame: 30 weeks
Viable neonate after 30 weeks of gestation per initiated cycle
30 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cumulative live birth rate
Time Frame: One year
Viable neonate after 30 weeks of gestation after one fresh and/or one frozen-warmed transfer per initiated cycle
One year
Ongoing pregnancy rate
Time Frame: 12 weeks of gestation
Continued pregnancy after 12 weeks of gestation per initiated cycle
12 weeks of gestation
Cumulative ongoing pregnancy rate
Time Frame: 12 weeks of gestation
Continued pregnancy after 12 weeks of gestation per initiated cycle within one year of randomization
12 weeks of gestation
Clinical pregnancy rate
Time Frame: 7 weeks of gestation
Ultrasound detect heartbeat after 7 weeks of gestation per initiated cycle
7 weeks of gestation
Cumulative clinical pregnancy rate
Time Frame: 7 weeks of gestation
Ultrasound detect heartbeat after 7 weeks of gestation per initiated cycle within one year of randomization
7 weeks of gestation
Implantation rate
Time Frame: 7 weeks of gestation
Number of sacs with a heartbeat per number of embryo transferred
7 weeks of gestation
Cumulative implantation rate
Time Frame: 7 weeks of gestation
Number of sacs with a heartbeat per number of embryo transferred within one year of randomization
7 weeks of gestation
Ongoing implantation rate
Time Frame: 12 weeks of gestation
Number of sacs with a heartbeat per number of embryo transferred
12 weeks of gestation
Cumulative ongoing implantation rate
Time Frame: 12 weeks of gestation
Number of sacs with a heartbeat per number of embryo transferred within one year of randomization
12 weeks of gestation
Preterm birth rate
Time Frame: 37 weeks
number of babies born before 37 weeks of gestation per total birth
37 weeks
Very preterm birth
Time Frame: 32 weeks
number of babies born before 32 weeks of gestation per total birth
32 weeks
Low birth weight rate
Time Frame: 40 weeks of gestation
number of babies with < 2500 gm per total birth
40 weeks of gestation
Fertilization rate
Time Frame: 6 days of culture
fertilized oocytes with two pronuclei per Metaphase II injected
6 days of culture
Cleavage rate
Time Frame: 6 days of culture
Cleaved embryo per fertilized oocyte
6 days of culture
Rate of high-quality day-3 embryos
Time Frame: 6 days of culture
Embryos with seven or eight blastomeres of appropriate-size, and < 10% fragmentation by volume per fertilized oocyte
6 days of culture
Blastocyst formation rate
Time Frame: 6 days of culture
Formed blastocyst on day 5/6 from fertilized oocytes
6 days of culture
Rate of high-quality blastocyst
Time Frame: 6 days of culture
Blastocysts ≥ 3.1.1 grade per fertilized oocyte
6 days of culture
Rate of utilizable blastocyst
Time Frame: 6 days of culture
Transferred and cryopreserved blastocysts from fertilized oocytes
6 days of culture

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2019

Primary Completion (Actual)

March 27, 2020

Study Completion (Actual)

March 27, 2020

Study Registration Dates

First Submitted

January 27, 2019

First Submitted That Met QC Criteria

January 29, 2019

First Posted (Actual)

January 30, 2019

Study Record Updates

Last Update Posted (Actual)

June 11, 2020

Last Update Submitted That Met QC Criteria

June 9, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IbnSina-Humidity

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infertility

Clinical Trials on Human embryo culture

Subscribe